Stock Picks: Three Biotech Big-Caps to Look At

... candidate, PRO-140. PRO 140 is a monoclonal antibody-based antiretroviral drug that belongs to a new class of HIV/AIDS drugs. The drug prevents the virus from entering healthy cells-it protects CCR5, the "molecular portal" HIV uses to bind to ...

http://ift.tt/1iYOZqj